“…Vagus nerve stimulation (VNS) has been approved by the Food and Drug Administration for the treatment of refractory epilepsy and depression and more recently, is being studied for its applications in obesity, Alzheimer's disease, heart failure, and inflammatory disease (Tracey, 2002, Li et al, 2004, Groves and Brown, 2005, Milby et al, 2008, Schwartz et al, 129 2008. Given that the vagus nerve would not be distinguishable from sympathetic fibers once it enters the abdominal region (Shoja M., 2013), the most common area of access to the nerve for stimulation would be on the cervical vagus.…”